LintonPharm Co.,Ltd.   Report issue

For profit Phase 3
Founded: Guangzhou China (2017)

Organization Overview

First Clinical Trial
2020
NCT04222114
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

LintonPharm Co.,Ltd.